Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Colloquium co-supported by Thermo Fisher Scientific and Eli Lilly - Multiplex biomarker profiling in contemporary oncology: From testing to understanding and impacting

Molecular tumour boards and application in oncology networks: Challenges and opportunities on the road towards optimizing patient benefit

Date

20 Sep 2021

Session

ESMO Colloquium co-supported by Thermo Fisher Scientific and Eli Lilly - Multiplex biomarker profiling in contemporary oncology: From testing to understanding and impacting

Presenters

Rodrigo Dienstmann

Authors

R. Dienstmann

Author affiliations

  • Oncology Data Science Department, Grupo Oncoclinicas, 04543-906 - Sao Paulo/BR

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.